Your browser doesn't support javascript.
loading
Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a.
de Queiroz, Eveline A I F; Akamine, Eliana H; de Carvalho, Maria Helena C; Sampaio, Sandra C; Fortes, Zuleica B.
Affiliation
  • de Queiroz EA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil; Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. Electronic address: evefarma@yahoo.com.br.
  • Akamine EH; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • de Carvalho MH; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Sampaio SC; Laboratory of Pathophysiology, Butantan Institute, São Paulo, Brazil.
  • Fortes ZB; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Electronic address: zbfortes@icb.usp.br.
Life Sci ; 121: 78-87, 2015 Jan 15.
Article in En | MEDLINE | ID: mdl-25497710

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium Glutamate / Carcinoma 256, Walker / Cyclic AMP-Dependent Protein Kinases / Forkhead Transcription Factors / Food Additives / Hypoglycemic Agents / Metformin / Obesity Type of study: Prognostic_studies Limits: Animals Language: En Journal: Life Sci Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium Glutamate / Carcinoma 256, Walker / Cyclic AMP-Dependent Protein Kinases / Forkhead Transcription Factors / Food Additives / Hypoglycemic Agents / Metformin / Obesity Type of study: Prognostic_studies Limits: Animals Language: En Journal: Life Sci Year: 2015 Document type: Article